MRP has been identified as another multidrug-resistance (MDR) gene and may be involved in an alternative MDR mechanism in some solid tumors. We investigated the expres- sion of M R P mRNA in multidrug-resistant KB sublines (KB-8-5, KB-CZ, C -W and C A I to), human non-small-cell lung carcinomas (NSC
Expression and prognostic significance of multidrug resistance associated protein (MRP) gene in non-small cell lung cancer by in site hybridization
β Scribed by Gen-fa Shan; Hong Zhong; Fu-xian Zhang; Guo-qing Li; Guilin Long; He-ding Gu; Xiao-min Qi
- Publisher
- Chinese Anti-Cancer Association
- Year
- 2000
- Tongue
- English
- Weight
- 293 KB
- Volume
- 12
- Category
- Article
- ISSN
- 1000-9604
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
Human non-small-cell lung cancer (NSCLC) is considered to be a chemotherapy-refractory malignancy. The underlying mechanisms remain rather obscure. The multidrug resistanceassociated protein (MRP), mediating a multidrug resistance (MDR) phenotype, has been reported to be overexpressed in several dru
Resistance to chemotherapy is intrinsically present in most nonsmall-cell lung carcinomas (NSCLC). No parameter has yet been determined to predict the response to chemotherapy. However, MRP1 (multidrug resistance-associated protein) is suspected to play an important role in resistance to treatment.